1. Home >
  2. Companies >
  3. Private >
  4. Life Science >
  5. United States >
  6. North Carolina >
  7. Cempra Pharmaceuticals >
  8. M&A

Cempra Pharmaceuticals Mergers & Acquisitions

Cempra Pharmaceuticals M&A Summary

Cempra Pharmaceuticals has acquired 1 company. A total of 1 acquisition came from private equity firms. It has also divested 1 asset.

It’s largest disclosed sale occurred in 2025, when it sold Melinta Therapeutics to CorMedix for $300M. Cempra Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity1
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 3

Cempra Pharmaceuticals, Inc.

Building Four Quadrangle 6340 Quadrangle Drive, Suite 100,
Chapel Hill, North Carolina 27517
United States,
(919) 576-2306
www.cempra.com

All (2) Buy (1) Sell (1)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2025-08-07 Melinta Therapeutics · Life Science
Parsippany, New Jersey · www.melinta.com

Melinta Therapeutics is a molecule drug discovery and development company focused on the structure-based design of new classes of antibiotics. Melinta Therapeutics is based in New Haven, Connecticut.

300 Divestiture

CorMedix
Advisors: Moelis & Co. , RBC Capital Markets , Willkie Farr & Gallagher

Cempra Pharmaceuticals, Inc.


Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal